RNLX Renalytix PLC

BTIG analyst Mark Massaro reiterated a Buy rating on Renalytix AI (RNLX - Research Report) on November 30 and set a price target of $4.00. The company's shares closed yesterday at $2.09.Massaro covers the Healthcare sector, focusing on stocks such as Exact Sciences, T2 Biosystems, and Natera. According to TipRanks, Massaro has an average return of -5.7% and a 38.35% success rate on recommended stocks. Currently, the analyst consensus on Renalytix AI is a Moderate Buy with an average price target of $6.00, a 187.08% upside from current levels. In a report released yesterday, H.C. Wainwright also reiterated a Buy rating on the stock with a $8.00 price target.
https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-renalytix-ai-rnlx?utm_source=advfn.com&utm_medium=referral